Offerings // Genenta Science S.p.A.

GNTA offering history

Every offering-related filing in Genenta Science S.p.A.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 111 filings back to Mar 1, 2021.

Last executed offering
Jan 27, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
May 12, 2023
F-3 — capacity, not a sale
Executed, last 12 months
2
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Jan 27, 2026424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 28, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 28, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 20, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 26, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 24, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
May 12, 2023F-3REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 15, 2021424B1EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Dec 15, 2021424B1EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Dec 14, 2021F-1MEFREGISTEREDF-1MEF registration — capacity to sell shares, not a sale yet
Dec 14, 2021EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 7, 2021F-1/AREGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 24, 2021F-1/AREGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 9, 2021F-1REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
GNTA offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GNTA workspace →
GNTA offering FAQ

When did GNTA last execute an offering?

Per SEC filings, Genenta Science S.p.A.'s most recent priced offering document is a 424B5 filed 2026-01-27. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GNTA last announce or register an offering?

The most recent registration is a F-3 filed 2023-05-12. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.